$ALGM

Hagen Erin sold $101K of ALGM

Hagen Erin (SVP, CHRO) sold 2,285 shares of ALLEGRO MICROSYSTEMS, INC. (ALGM) at $44.39 ($0.10M total) on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hagen Erin
Published Aug 12, 2026, 8:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ALGM
Neutral
medium confidence
Mentioned
$ALGM
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALGMNeutralLow
01

Why it matters

The only new information is the specific sale details (shares, price, total value) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 structure reduces interpretive weight versus discretionary selling.

03

What to watch

The filing does not indicate whether other insiders sold/bought around the same window, nor does it provide any new guidance or business developments.

Relevance 3/10Novelty 3/10Timing: filed Aug. 12 after-hours; sale executed Aug. 10

Background

The article is a SEC Form 4 insider transaction disclosure for Allegro Microsystems, Inc. (ALGM).

Company-level read

Ticker impact

$ALGMNeutralMedium confidence
Context

ALGM disclosed a Form 4 showing SVP CHRO Hagen Erin sold 2,285 shares at $44.39 on Aug. 10 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by other company-specific news.

Evidence & confidence

The filing provides transaction size, price, and 10b5-1 status, but no new operational, financial, or regulatory information about ALGM.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

10b5-1 sales can coincide with routine liquidity needs and do not necessarily reflect bearish views; the market may overreact to the headline.

Key entities

  • ALLEGRO MICROSYSTEMS, INC.

    Subject of the Form 4 insider transaction disclosure.

  • Hagen Erin

    SVP, CHRO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALGMHighAI 9/10

ALLEGRO MICROSYSTEMS, INC. (ALGM): Results of Operations and Financial Condition

ALLEGRO MICROSYSTEMS, INC. (ALGM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Allegro MicroSystems Reports First Quarter 2027 Results First Quarter Sales Increased by 27% Year-over-Year to $259 Million Manchester, NH, July 30, 2026 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM ), a global leader in power and sensing s

$LITEMed

Barclays upgrades Lumentum, cuts Allegro, Penguin before chip earnings By Investing.com

Barclays adjusted ratings on U.S. semiconductor stocks ahead of Q2 earnings. It upgraded Lumentum Holdings to Overweight from Equal Weight, citing improving AI networking demand confidence and stronger earnings potential. It downgraded Allegro MicroSystems to Equal Weight and Penguin Solutions to Underweight, citing valuation and weaker near-term fundamentals. Barclays kept Credo Technology Overweight and Astera Labs Equal Weight.

$ALGMMed

TD Cowen Raises PT on Allegro MicroSystems (ALGM)

TD Cowen analyst Joshua Buchalter raised Allegro MicroSystems’ (ALGM) price target from $55 to $70 and kept a Buy rating, after updating the firm’s financial model, according to the report. TD Cowen expects investors to re-rate ALGM’s exposure to automotive and AI data-center growth and projects profitable mid-teen long-term growth.